Old and new interventional therapies in the treatment of symptomatic benign prostate hyperplasia (BPH);Alte und neue interventionelle therapien zur behandlung der symptomatischen benignen prostatahyperplasie (BPH)

Therapeutische Umschau

Volumn 63, Issue 2, 2006, Pages 129-134

  Muller R M ^a   Thalmann, G N ^a   Studer, U E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANDROGEN BLOOD LEVEL; BLADDER CAPACITY; BLADDER NECK; COMORBIDITY; DIODE LASER; ESTROGEN BLOOD LEVEL; HOLMIUM LASER; HUMAN; INTERMETHOD COMPARISON; MALE; MICTURITION; MINIMALLY INVASIVE SURGERY; MUSCLE TONE; PROSTATE HYPERTROPHY; RESIDUAL URINE; REVIEW; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; THERMAL INJURY; TISSUE NECROSIS; TRANSURETHRAL ELECTROVAPORIZATION; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA; URINARY TRACT OBSTRUCTION; URODYNAMICS;

CATHETER ABLATION; HUMANS; LASER SURGERY; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROSTATECTOMY; PROSTATIC HYPERPLASIA; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 32844461833     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.63.2.129     Document Type: Review

References (19)

1. Boyle P, Robertson C, Lowe F, Roehrborn C. Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 2000; 55: 533.
2. Wasson JH, Reda DJ, Bruskewitz RC, et al. A comparison of trans-urethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 1995; 332: 75.
3. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guide, AHCPR Pub. No. 94-0582, US Dept of Health and Human Services, 1994.
4. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 1992; 148: 1549.
5. Hochreiter W, Mueller RM. Lasers for urinary tract symptoms secondary to benign prostatic hyperplasia: when is the fuss worth it? Curr Urol Rep 2005; 6: 257.
6. Kuntz RM, Fayad A, Lehrich K, et al. Transurethral holmium laser enucleation of the prostate (HoLEP): a prospective study on 100 patients with one year follow-up. Med Laser Appl 2001; 16: 15.
7. Hochreiter WW, Thalmann GN, Burkhard FC, et al. Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol 2002; 168: 1470.
8. Volkan T, Ihsan TA, Yilmaz O, et al.Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 2005; 48(4): 608.
9. Bachmann A, Ruszat R, Wyler S, et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 2005; 47(6): 798.
10. Kumar SM. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J Urol 2005 Feb; 173(2): 511.
11. Jung P, Mattelaer P, Wolff JM, et al. Visual laser ablation of the prostate: efficacy evaluated by urodynamics and compared to TURP. Eur Urol 1996; 30(4): 418.
12. Jung P, Mattelaer P, Wolff JM, et al. Visual laser ablation of the prostate: efficacy evaluated by urodynamics and compared to TURP. Eur Urol 1996; 30(4): 418.
13. Norris JP, Norris DM, Lee RD, et al. Visual laser ablation of the prostate: clinical experience in 108 patients. J Urol 1993; 150: 1612.
14. Thalmann GN, Graber SF, Bitton A, et al. Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: results in 134 patients after 1 year. J Urol 1999; 162(2): 387.
15. Thalmann GN, Mattei A, Treuthardt C, et al. Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results. J Urol 2002; 167(6): 2496.
16. Zlotta AR, Giannakopoulos X, Maehlum O, et al. Longterm evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol 2003; 44(1): 89.
17. Hill B, Belville W, Bruskewitz R, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004; 171: 2336.
18. Muschter R. Conductive heat: hot water-induced thermotherapy for ablation of prostatic tissue. J Endourol 2003; 17(8): 609.
19. Corica AG, Qian J, Ma J, et al. Fast liquid ablation system for prostatic hyperplasia: a new minimally invasive thermal treatment. J Urol 2003; 170(3): 874.